17th December 2024
Category: Press Releases
29th October 2024
Vizgen to Present Clinical Research Case Study and Research Findings at Society for Immunotherapy of Cancer (SITC) Annual Meeting
9th October 2024
Vizgen and Ultivue Merge to Enable Deeper Insights into Disease Mechanisms and Drive Innovation in Spatial Multiomics
24th September 2024
Vizgen Announces First Worldwide Shipments of MERSCOPE Ultra™, Ushering in a New Frontier in Spatial Genomics
7th May 2024
Vizgen Announces Significant Win in Ongoing Patent Litigation Against 10x Genomics and Harvard University
16th April 2024
Vizgen Issued a New US Patent for Its MERFISH Technology
8th April 2024
Vizgen Expands Single-Cell Spatial Transcriptomics Offering with Introduction of MERSCOPE® Ultra Platform and MERFISH 2.0 Chemistry at AACR 2024
13th March 2024
Vizgen Announces Denial of 10x Genomics’ Petition for Inter Partes Review of Vizgen-Licensed Patent Currently Asserted Against 10x’s Xenium Platform
8th March 2024
With Capital Raise, Vizgen Commits to Its Long-term Success and Defense Against Baseless Anti-Competitive Legal Actions
5th February 2024